{"id":"mecloralurea","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"ligerium","offLabel":[],"synonyms":["mecloralurea","heraldium","ligerium","trichloroethylolmethylurea"],"timeline":[],"approvals":[],"brandName":"Ligerium","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells have locks on them, and Ligerium is a key that fits into one of those locks. When it binds to the lock, it triggers a series of events that ultimately lead to a desired outcome, such as treating a disease or condition. This is a simplified explanation of how Ligerium works at a molecular level.","oneSentence":"Ligerium works by interacting with a specific molecular target to produce a therapeutic effect.","technicalDetail":"Ligerium's mechanism of action is likely to involve binding to a specific protein or receptor, which triggers a downstream signaling cascade that ultimately leads to a therapeutic effect. The exact details of this process are unclear, but it is likely to involve complex interactions between Ligerium and various molecular targets within the cell."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3767","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=MECLORALUREA","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T14:17:02.399813","biosimilars":[],"competitors":[],"genericName":"mecloralurea","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"9QXZ0A5J81","CHEBI":"CHEBI:134910","INN_ID":"2442","UMLSCUI":"C0601649","ChEMBL_ID":"CHEMBL1902645","PUBCHEM_CID":"71808","MESH_SUPPLEMENTAL_RECORD_UI":"C002923"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ligerium (MECLORALUREA) is a small molecule compound with unknown target and drug class. Its commercial status is unclear, and it is not FDA approved for any indications. As a small molecule, it is likely to be administered orally, but its pharmacokinetic properties such as half-life and bioavailability are unknown. The compound's ownership and off-patent status are also unclear. Further research is needed to determine its potential therapeutic applications and safety profile.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}